TITAN decreaser macroinvertebrate heatmap Heatmap of sensitive (i.e., <i>z-</i>) macroinvertebrate taxa (y-axis) to at least one of the five stressors, in decreasing order of numbe... by Brent J. Bellinger (21156150)

TITAN decreaser diatom heatmap. by Brent J. Bellinger (21156150)

Table of values for <i>p.</i> by Long Di (9977453)

Decrease in loss during the training process. by Muhammad Idrees (92773)

Average Gait Speed (A), Cadence (B), Step Length (C), and Walk Ratio (D) across Terrains; Violin plots with individual participant data of A) gait speed, B) cadence, C) average ste... by Benjamin S. Killen (22766029)

Subjects:

Diagram of Outdoor Terrains; Participants performed two loops (clockwise and counterclockwise). by Benjamin S. Killen (22766029)

Subjects:

Results of Multiple Linear Regression. by Benjamin S. Killen (22766029)

Subjects:

Spatiotemporal Gait Parameters Across Terrains. by Benjamin S. Killen (22766029)

Subjects:

Participant Demographic Information. by Benjamin S. Killen (22766029)

Subjects:

The multiple criteria qualitative value-based pricing framework “MARIE” for new clinical status by Akina Takami (16407200)

“…However, the failure to incorporate a drug’s value when determining its price decreases pharmaceutical companies’ motivation to develop and launch novel drugs in Japan.…”

<i>r</i>² values for <i>α</i> relationships. by James Cushway (19942288)

TITAN increaser macroinvertebrate heatmap Heatmap of tolerant (i.e., <i>z</i>+) macroinvertebrate taxa (y-axis) to at least one of the five stressors, in decreasing order of number... by Brent J. Bellinger (21156150)

Lymphocytes decreased in mouse pneumonia model. by Qi Xu (134661)

Decreased <i>Notch3</i> asymmetry in <i>Nodal</i> mutants. by Tobias Holm Bønnelykke (20968460)

The values calculated for the inhibitor dissociation constant, as detailed in Eqs 10 and 11 and approximated values for the binding rate constants of the inhibitors. by J. Roadnight Sheehan (20141887)

Observed values, synthetic control estimates, causal effects, with confidence intervals, by country and moral foundation. by Daniel Hart (440152)

Subjects:

Changes in HSA outcomes between baseline and six months (N = 60). by Janelli Vallin (14540858)

Subjects:

<i>JRC</i> values of concrete joint specimens of each group. by Zhezhe Zhang (19704587)

Numeric values used to generate all the graphs presented in the figures. by Wenjia Yu (9422059)

Impact of changes in competitive strength of direct marketing channels on pharmaceutical pricing and profits. by Yan Wen (416285)